[go: up one dir, main page]

EP2341941A4 - HEPAROSANE POLYMERS AND METHODS OF MAKING AND USING THEM TO ENHANCE THERAPEUTIC COMPOUNDS - Google Patents

HEPAROSANE POLYMERS AND METHODS OF MAKING AND USING THEM TO ENHANCE THERAPEUTIC COMPOUNDS

Info

Publication number
EP2341941A4
EP2341941A4 EP09813350.7A EP09813350A EP2341941A4 EP 2341941 A4 EP2341941 A4 EP 2341941A4 EP 09813350 A EP09813350 A EP 09813350A EP 2341941 A4 EP2341941 A4 EP 2341941A4
Authority
EP
European Patent Office
Prior art keywords
heparosane
polymers
making
methods
therapeutic compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09813350.7A
Other languages
German (de)
French (fr)
Other versions
EP2341941A2 (en
Inventor
Paul L Deangelis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Oklahoma
Original Assignee
University of Oklahoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Oklahoma filed Critical University of Oklahoma
Publication of EP2341941A2 publication Critical patent/EP2341941A2/en
Publication of EP2341941A4 publication Critical patent/EP2341941A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP09813350.7A 2008-09-09 2009-09-09 HEPAROSANE POLYMERS AND METHODS OF MAKING AND USING THEM TO ENHANCE THERAPEUTIC COMPOUNDS Withdrawn EP2341941A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9557208P 2008-09-09 2008-09-09
US38304609A 2009-03-19 2009-03-19
US17927509P 2009-05-18 2009-05-18
PCT/US2009/005050 WO2010030342A2 (en) 2008-09-09 2009-09-09 Heparosan polymers and methods of making and using same for the enhancement of therapeutics

Publications (2)

Publication Number Publication Date
EP2341941A2 EP2341941A2 (en) 2011-07-13
EP2341941A4 true EP2341941A4 (en) 2014-12-10

Family

ID=44123336

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09813350.7A Withdrawn EP2341941A4 (en) 2008-09-09 2009-09-09 HEPAROSANE POLYMERS AND METHODS OF MAKING AND USING THEM TO ENHANCE THERAPEUTIC COMPOUNDS

Country Status (3)

Country Link
EP (1) EP2341941A4 (en)
CA (1) CA2773755C (en)
WO (1) WO2010030342A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580290B2 (en) 2001-05-08 2013-11-12 The Board Of Regents Of The University Of Oklahoma Heparosan-based biomaterials and coatings and methods of production and use thereof
US9687559B2 (en) 2008-03-19 2017-06-27 The Board Of Regents Of The University Of Oklahoma Heparosan polymers and methods of making and using same for the enhancement of therapeutics
US9925209B2 (en) 2008-03-19 2018-03-27 The Board Of Regents Of The University Of Oklahoma Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same
WO2013149161A1 (en) 2012-03-30 2013-10-03 Deangelis Paul L High molecular weight heparosan polymers and methods of production and use thereof
RU2623283C2 (en) 2012-09-17 2017-06-23 Текнип Франс Trusses spar with vertical plates for suppression of oscillations caused by vortex formation
JP2015532307A (en) * 2012-10-15 2015-11-09 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー Coagulation factor VII polypeptide
CN104661685A (en) * 2012-10-15 2015-05-27 诺和诺德保健Ag（股份有限公司） Factor vii conjugates
BR112016008039A2 (en) 2013-10-15 2017-10-17 Novo Nordisk Healthcare Ag coagulation factor vii polypeptides
AR099340A1 (en) * 2014-02-12 2016-07-13 Novo Nordisk As CONJUGATES OF THE COAGULATION FACTOR IX
AR101060A1 (en) * 2014-02-12 2016-11-23 Novo Nordisk As FVIII CONJUGATES

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022331A1 (en) * 1991-06-06 1992-12-23 The School Of Pharmacy Pharmaceutical compositions
WO1997041897A1 (en) * 1996-05-09 1997-11-13 Virion Systems, Inc. Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones
US20020192205A1 (en) * 2001-05-11 2002-12-19 Francis Michon Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group A and group C streptococci
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US20040087488A1 (en) * 2002-07-02 2004-05-06 Genzyme Corporation Hydrophilic biopolymer-drug conjugates, their preparation and use
US20040197868A1 (en) * 2001-05-08 2004-10-07 Deangelis Paul L. Heparin/heparosan synthase from P. multocida, soluble and single action catalysts thereof and methods of making and using same
US20060105431A1 (en) * 1998-11-11 2006-05-18 Deangelis Paul L Polymer grafting by polysaccharide synthases using artificial sugar acceptors
US20060116346A1 (en) * 2002-10-18 2006-06-01 Fidia Farmaceutici S.P.A. Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
EP1870421A1 (en) * 2005-03-31 2007-12-26 Seikagaku Corporation Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
US20080109236A1 (en) * 1998-04-02 2008-05-08 Deangelis Paul L Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases
US20080112951A1 (en) * 2003-07-04 2008-05-15 Armelle Phalipon Glycoconjugates and Their Use as Potential Vaccines Against Infection by Shigella Flexneri
EP1923402A1 (en) * 2005-06-28 2008-05-21 Seikagaku Corporation Method for determination of enzymatic activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US7291673B2 (en) * 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US6833488B2 (en) * 2001-03-30 2004-12-21 Exotech Bio Solution Ltd. Biocompatible, biodegradable, water-absorbent material and methods for its preparation
US8580290B2 (en) * 2001-05-08 2013-11-12 The Board Of Regents Of The University Of Oklahoma Heparosan-based biomaterials and coatings and methods of production and use thereof
US6623729B2 (en) * 2001-07-09 2003-09-23 Korea Advanced Institute Of Science And Technology Process for preparing sustained release micelle employing conjugate of anticancer drug and biodegradable polymer
US7655445B2 (en) * 2003-11-12 2010-02-02 Massachusetts Institute Of Technology Methods for synthesis of sulfated saccharides

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022331A1 (en) * 1991-06-06 1992-12-23 The School Of Pharmacy Pharmaceutical compositions
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
WO1997041897A1 (en) * 1996-05-09 1997-11-13 Virion Systems, Inc. Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones
US20080109236A1 (en) * 1998-04-02 2008-05-08 Deangelis Paul L Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases
US20060105431A1 (en) * 1998-11-11 2006-05-18 Deangelis Paul L Polymer grafting by polysaccharide synthases using artificial sugar acceptors
US20040197868A1 (en) * 2001-05-08 2004-10-07 Deangelis Paul L. Heparin/heparosan synthase from P. multocida, soluble and single action catalysts thereof and methods of making and using same
US20020192205A1 (en) * 2001-05-11 2002-12-19 Francis Michon Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group A and group C streptococci
US20040087488A1 (en) * 2002-07-02 2004-05-06 Genzyme Corporation Hydrophilic biopolymer-drug conjugates, their preparation and use
US20060116346A1 (en) * 2002-10-18 2006-06-01 Fidia Farmaceutici S.P.A. Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
US20080112951A1 (en) * 2003-07-04 2008-05-15 Armelle Phalipon Glycoconjugates and Their Use as Potential Vaccines Against Infection by Shigella Flexneri
EP1870421A1 (en) * 2005-03-31 2007-12-26 Seikagaku Corporation Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
EP1923402A1 (en) * 2005-06-28 2008-05-21 Seikagaku Corporation Method for determination of enzymatic activity

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A. E. SISMEY-RAGATZ ET AL: "Chemoenzymatic Synthesis with Distinct Pasteurella Heparosan Synthases: MONODISPERSE POLYMERS AND UNNATURAL STRUCTURES", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 282, no. 39, 11 July 2007 (2007-07-11), pages 28321 - 28327, XP055116675, ISSN: 0021-9258, DOI: 10.1074/jbc.M701599200 *
KIYOSHI SUZUKI ET AL: "Generation and characterization of a series of monoclonal antibodies that specifically recognize [HexA(Ã Â+-2S)-GlcNAc]n epitopes in heparan sulfate", GLYCOCONJUGATE JOURNAL, KLUWER ACADEMIC PUBLISHERS, BO, vol. 25, no. 8, 7 May 2008 (2008-05-07), pages 703 - 712, XP019642419, ISSN: 1573-4986, DOI: 10.1007/S10719-008-9130-Z *

Also Published As

Publication number Publication date
CA2773755A1 (en) 2010-03-18
WO2010030342A2 (en) 2010-03-18
CA2773755C (en) 2017-04-25
WO2010030342A3 (en) 2010-06-17
EP2341941A2 (en) 2011-07-13

Similar Documents

Publication Publication Date Title
EP2341941A4 (en) HEPAROSANE POLYMERS AND METHODS OF MAKING AND USING THEM TO ENHANCE THERAPEUTIC COMPOUNDS
EP2385944A4 (en) FLUORINATED COMPOUNDS AND METHODS OF USE
EP2507245A4 (en) MULTICYCLIC COMPOUNDS AND METHODS OF USE
EP2152256A4 (en) TELOMERASE-ENHANCING COMPOUNDS AND METHODS OF USE
EP2462138A4 (en) ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING SAME, AND REFERENCE TO CORRESPONDING APPLICATIONS
EP2279291A4 (en) COFERONS AND THEIR METHODS OF MANUFACTURE AND USE
EP2217577A4 (en) NOVEL COMPOUNDS AND NOVEL COMPOSITIONS AND METHODS OF USE
EP2283358A4 (en) IMMUNOMODULANT COMPOSITIONS AND METHODS OF USE
EP2209756A4 (en) AGRICULTURAL COMPOSITIONS AND METHODS OF MAKING AND USING THEM
EP2300011A4 (en) METHODS AND THERAPEUTIC COMPOUNDS
EP2651415A4 (en) GASTRIC AND COLIC FORMULATIONS AND METHODS OF MAKING AND USING SAME
EP2693875A4 (en) BISPHENOL COMPOUNDS AND METHODS OF USE
EP2609183A4 (en) UNITARY DETERGENT COMPOSITIONS AND METHODS OF MAKING AND USING SAME
EP2804851A4 (en) THERAPEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE
EP2800743A4 (en) THERAPEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE
EP2663565A4 (en) HETEROARYL COMPOUNDS AND METHODS OF USE
EP2309860A4 (en) MONOCYCLIC CYANOENONES AND METHODS OF USE
EP2569425A4 (en) ENDORIBONUCLEASE COMPOSITIONS AND METHODS OF USE
EP2293668A4 (en) ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE
EP2606004A4 (en) ISOTOPICALLY ENHANCED BORON-CONTAINING COMPOUNDS, AND METHODS OF MAKING AND USING SAME
EP2209375A4 (en) PARP INHIBITING COMPOUNDS, COMPOSITIONS AND METHODS OF USE
EP2533686A4 (en) POLYMER FILM BIOELECTRODES AND METHODS OF MAKING AND USING THE SAME
EP2539473A4 (en) MODIFIED PROTEINS AND METHODS OF MAKING AND USING THE SAME
EP2552196A4 (en) SILICA MULTIFUNCTIONAL COMPOSITIONS AND GELS, METHODS OF MAKING SAME, AND METHODS OF USING SAME
EP2672820A4 (en) MANNOSID COMPOUNDS AND METHODS OF USE

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110408

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20141110

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/10 20060101ALI20141104BHEP

Ipc: A61K 47/36 20060101ALI20141104BHEP

Ipc: A61K 47/48 20060101AFI20141104BHEP

Ipc: A61K 9/00 20060101ALI20141104BHEP

17Q First examination report despatched

Effective date: 20160901

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190221